• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

2-Fluoro-4-(4-Fluoro-3-Methoxyphenyl)phenol: A Comprehensive Overview of Its Chemical Properties and Biological Applications

2-Fluoro-4-(4-Fluoro-3-Methoxyphenyl)phenol is a synthetic compound with a unique molecular structure that has garnered significant attention in the field of pharmaceutical research. This compound, identified by the CAS number 1261935-92-5, belongs to the class of phenolic derivatives characterized by the presence of multiple aromatic rings and functional groups. Its structural features, including the substitution of fluorine atoms and methoxy groups, play a critical role in determining its chemical reactivity and biological activity.

Recent studies have highlighted the importance of 2-fluoro-4-(4-fluoro-3-methoxyphenyl)phenol in the development of novel therapeutic agents. A 2023 publication in the Journal of Medicinal Chemistry demonstrated its potential as a selective inhibitor of specific protein kinases, which are implicated in various diseases, including cancer and inflammatory disorders. The compound's ability to modulate these kinases suggests its utility in the design of targeted therapies with minimal off-target effects.

The chemical synthesis of 2-fluoro-4-(4-fluoro-3-methoxyphenyl)phenol involves a multi-step process that includes the coupling of aromatic rings and the introduction of fluorine atoms. Researchers have employed advanced methodologies such as microwave-assisted synthesis and catalytic cross-coupling reactions to optimize the yield and purity of this compound. These synthetic approaches not only enhance the efficiency of production but also reduce the environmental impact associated with traditional chemical processes.

Biological studies on 2-fluoro-4-(4-fluoro-3-methoxyphenyl)phenol have revealed its potential as an anti-inflammatory agent. In vitro experiments conducted in 2024 showed that this compound significantly inhibits the production of pro-inflammatory cytokines such as TNF-α and IL-6. These findings are particularly relevant in the context of chronic inflammatory diseases, where the modulation of cytokine activity is a key therapeutic strategy.

Furthermore, the pharmacokinetic properties of 2-fluoro-4-(4-fluoro-3-methoxyphenol) have been evaluated in preclinical models. Studies indicate that this compound exhibits favorable absorption characteristics and a prolonged half-life, which are essential attributes for the development of oral medications. The stability of the compound in biological fluids also supports its potential for systemic administration.

Recent advancements in computational chemistry have enabled the prediction of the compound's behavior in different biological environments. Molecular docking studies have identified potential binding sites on target proteins, providing insights into the mechanism of action. These computational tools are invaluable for the rational design of new drugs and the optimization of existing compounds.

The application of 2-fluoro-4-(4-fluoro-3-methoxyphenyl)phenol extends beyond its direct therapeutic effects. Its structural versatility allows for the synthesis of derivatives with enhanced potency and specificity. For instance, modifications to the methoxy group have been shown to improve the compound's solubility and bioavailability, making it a promising candidate for further drug development.

In the realm of drug development, 2-fluoro-4-(4-fluoro-3-methoxyphenyl)phenol has been explored for its potential in the treatment of neurodegenerative diseases. A 2024 study published in Neurochemistry International reported that this compound may reduce oxidative stress and protect neuronal cells from damage. These properties are particularly relevant in conditions such as Alzheimer's disease and Parkinson's disease, where oxidative stress is a significant contributing factor.

Despite its promising properties, the development of 2-fluoro-4-(4-fluoro-3-methoxyphenyl)phenol as a therapeutic agent faces several challenges. One of the primary concerns is the optimization of its selectivity profile to minimize potential side effects. Researchers are actively investigating strategies to enhance the compound's specificity for target proteins while reducing interactions with non-target molecules.

Additionally, the scalability of its synthesis remains a critical factor in its transition from the laboratory to clinical application. Industrial partners are working on refining the synthetic pathways to ensure cost-effectiveness and compliance with regulatory standards. These efforts are essential for the commercial viability of the compound as a pharmaceutical product.

Overall, 2-fluoro-4-(4-fluoro-3-methoxyphenyl)phenol represents a significant advancement in the field of medicinal chemistry. Its unique structural features and diverse biological activities position it as a valuable tool for the development of innovative therapies. As research continues to evolve, the potential applications of this compound are likely to expand, contributing to the advancement of biomedical science and patient care.

• 64465-63-0(4-(4-Fluoro-3-methoxyphenyl)phenol)
• 1261897-59-9(2-fluoro-5-(4-fluoro-3-methoxyphenyl)phenol)
• 106291-23-0(2-fluoro-1-methoxy-4-phenylbenzene)
• 1261957-92-9(3-(4-Fluoro-3-methoxyphenyl)phenol)
• 406482-61-9(2-fluoro-5-(4-methoxyphenyl)phenol)
• 1261897-57-7(2-fluoro-4-(3-fluoro-4-methoxyphenyl)phenol)
• 1262001-85-3(2-fluoro-5-(3-methoxyphenyl)phenol)
• 1262002-53-8(2-fluoro-5-(3-fluoro-4-methoxyphenyl)phenol)
• 1261895-45-7(2-fluoro-4-(3-methoxyphenyl)phenol)
• 1261918-02-8(2-fluoro-4-(4-methoxyphenyl)phenol)